Alterations of T Helper Lymphocyte Subpopulations in Sepsis, Severe Sepsis, and Septic Shock: A Prospective Observational Study

被引:0
|
作者
Jia Li
Ming Li
Longxiang Su
Huijuan Wang
Kun Xiao
Jie Deng
Yanhong Jia
Gencheng Han
Lixin Xie
机构
[1] the Chinese PLA General Hospital,Department of Respiratory Medicine
[2] Nankai University,School of medicine
[3] People’s Hospital of Tianjin,Department of Respiratory Medicine
[4] Chinese Academy of Medical Sciences,Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College
[5] Capital Medical University,Respiratory Medicine Department, Beijing Chao
[6] Beijing Institute of Basic Medical Sciences,Yang Hospital
来源
Inflammation | 2015年 / 38卷
关键词
septic shock; lymphocytes; T-bet; GATA-3; RORγt; FOXP3;
D O I
暂无
中图分类号
学科分类号
摘要
Circulating lymphocyte number was significantly decreased in patients with sepsis. However, it remains unknown which severity phase (sepsis, severe sepsis, and septic shock) does it develop and what happen on each subpopulation. Eight patients with differing severities of sepsis (31 sepses, 33 severe sepses, and 16 septic shocks) were enrolled. Quantitative real-time polymerase chain reaction (RT-PCR) of Th1, Th2, and Th17; regulatory T (Treg) cell-specific transcription factor T-bet; GATA-3; RORgammat (RORγt); forkhead box P3 (FOXP3); and IL-17 mRNA were performed, and the enzyme-linked immunosorbent assay (ELISA) was used to detect serum interferon (IFN)-γ, IL-4, and IL-10. In this study, the Th1, Th2, Treg transcription factors, and related cytokines IFN-γ, IL-4, and IL-10 levels of sepsis and severe sepsis patients in peripheral blood were significantly higher than those of the normal controls. Except for IL-17, the T-bet, GATA-3, and IFN-γ levels of septic shock patients were lower than those of sepsis patients. We also observed that the proportions of Th17/Treg in the sepsis and septic shock groups were inversed. From the above, the inflammatory response especially the adaptive immune response is still activated in sepsis and severe sepsis, but significant immunosuppression was developed in septic shock. In addition, the proportion of Th17/Treg inversed may be associated with the illness aggravation of patients with sepsis.
引用
收藏
页码:995 / 1002
页数:7
相关论文
共 50 条
  • [41] MANAGEMENT OF SEVERE SEPSIS IN ASIA: A PROSPECTIVE OBSERVATIONAL STUDY
    Phua, J.
    Koh, Y.
    Du, B.
    Divatia, J. V.
    Tan, C. C.
    Gomersall, C. D.
    Faruq, M. O.
    Shrestha, B. R.
    Nguyen, G. B.
    Arabi, Y.
    Salahuddin, N.
    Wahyuprajitno, B.
    Tu, M. L.
    Abd Wahab, A. Y. H.
    Hameed, A. A.
    Nishimura, M.
    Procyshyn, M.
    Chan, Y. H.
    [J]. INTENSIVE CARE MEDICINE, 2010, 36 : S425 - S425
  • [42] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    Dellinger, RP
    Carlet, JM
    Masur, H
    Gerlach, H
    Calandra, T
    Cohen, J
    Gea-Banacloche, J
    Keh, D
    Marshall, JC
    Parker, MM
    Ramsay, G
    Zimmerman, JL
    Vincent, JL
    Levy, MM
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (04) : 536 - 555
  • [43] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    Dellinger, RP
    Carlet, JM
    Masur, H
    Gerlach, H
    Calandra, T
    Cohen, J
    Gea-Banacloche, J
    Keh, D
    Marshall, JC
    Parker, MM
    Ramsay, G
    Zimmerman, JL
    Vincent, JL
    Levy, MM
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (03) : 858 - 873
  • [44] Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
    Martin, Greg S.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (06) : 701 - 706
  • [45] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    R. Phillip Dellinger
    Jean M. Carlet
    Henry Masur
    Herwig Gerlach
    Thierry Calandra
    Jonathan Cohen
    Juan Gea-Banacloche
    Didier Keh
    John C. Marshall
    Margaret M. Parker
    Graham Ramsay
    Janice L. Zimmerman
    Jean-Louis Vincent
    M. M. Levy
    [J]. Intensive Care Medicine, 2004, 30 : 536 - 555
  • [46] Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study
    Ong, David S. Y.
    Frencken, Jos F.
    Klouwenberg, Peter M. C. Klein
    Juffermans, Nicole
    van der Poll, Tom
    Bonten, Marc J. M.
    Cremer, Olaf L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 64 (12) : 1731 - 1736
  • [47] Severe Sepsis and Septic Shock: Timing of Septic Shock Onset Matters
    Huang, Chun-Ta
    Tsai, Yi-Ju
    Tsai, Pi-Ru
    Yu, Chong-Jen
    Ko, Wen-Je
    [J]. SHOCK, 2016, 45 (05): : 518 - 524
  • [48] Implementation of surviving sepsis campaign guidelines for severe sepsis and septic shock
    Zambon, M
    Vincent, JL
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A159 - A159
  • [49] THE ITALIAN SEPSIS STUDY - PRELIMINARY-RESULTS ON THE INCIDENCE AND EVOLUTION OF SIRS, SEPSIS, SEVERE SEPSIS AND SEPTIC SHOCK
    SALVO, I
    DECIAN, W
    MUSICCO, M
    LANGER, M
    PIADENA, R
    WOLFLER, A
    MONTANI, C
    MAGNI, E
    [J]. INTENSIVE CARE MEDICINE, 1995, 21 : S244 - S249
  • [50] The outcomes of severe sepsis and septic shock in the UK
    Adam D Reuben
    Andrew V Appelboam
    Ian Higginson
    [J]. Critical Care, 10